Cinclus Pharma to participate in the Stifel Healthcare Conference in New York

CEO Christer Ahlberg and Business Manager Jesper Wiklund will present the company and provide an update on the development of linaprazan glurate.

The conference brings together global investors and companies in pharmaceuticals, biotechnology and medical technology to discuss innovation, clinical progress and strategic developments in the industry.